Research Article
Analysis of Various Types of Glomerulonephritis with Crescents at a Single Center
Table 3
Univariate and multivariate analysis of factors affecting renal prognosis between type II and type III rapid progressive glomerulonephritis.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HR, hazard ratio; CI, confidence interval; MAP, mean arterial pressure; BMI, body mass index; Alb, serum albumin; eGFR, estimated glomerular filtration rate; T-chol, total cholesterol; TG, triglycerides; U-Prot, total urine protein; U-RBC, urine red blood cell count; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker. aGlobal glomerulosclerosis score: < 10%, 0; 10 ≤ lesion < 25%, 1; 25 ≤ lesion < 50%, 2; 50 ≤ lesion < 75%, 3; ≥75%, 4. bCrescent score: <10%, 0; 10 ≤ lesion < 25%, 1; 25 ≤ lesion < 50%, 2; 50 ≤ lesion < 75%, 3; ≥75%, 4. cTubular atrophy and interstitial fibrosis score: <5%, 0; 5 ≤ lesion < 20, 1; 20 ≤ lesion < 50, 2; ≥50, 3. dNormal glomeruli score: > 75%, 0; 50 < lesion ≤ 75, 1; 25 < lesion ≤ 50, 2; ≤ 25, 3. eArteriosclerosis and arteriolosclerosis score: none or low, 0; middle, 1; high, 2; and very high, 3. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||